Literature DB >> 31707840

Importance of Early Diagnosis in Peripartum Cardiomyopathy.

Jennifer Lewey1, Lisa D Levine2, Michal A Elovitz2, Olga C Irizarry2, Zoltan Arany1.   

Abstract

Peripartum cardiomyopathy (PPCM) can lead to long-term systolic dysfunction, especially among black women. Hypertensive disorders of pregnancy (HDP) are the strongest risk factor for PPCM, but controversy remains on whether HDP predict a favorable outcome. Women with HDP are also often diagnosed with PPCM earlier than those without HDP. Our objective is to determine recovery of systolic function in patients with PPCM stratified by HDP, timing of diagnosis, and race. We conducted a retrospective cohort study of 220 patients (55% black) diagnosed with PPCM. Patients with PPCM and HDP were diagnosed earlier postpartum than patients without HDP (P=0.013), an effect that was most pronounced in nonblack patients. Rates of left ventricular ejection fraction (LVEF) recovery were similar among PPCM patients with and without HDP (68.4% versus 62.6%, P=0.425). In contrast, patients with PPCM diagnosed after 1-month postpartum had lower rates of LVEF recovery than patients diagnosed <1-month postpartum (53.7% versus 69.9%, P=0.035). LVEF at time of diagnosis is a strong predictor of LVEF recovery, and patients with PPCM diagnosed after 1-month postpartum had lower baseline LVEF compared to patients presenting earlier (P=0.041). The presence of HDP does not correlate with LVEF recovery in our racially diverse PPCM cohort. In contrast, early diagnosis portends a favorable outcome. Early diagnosis is associated with higher LVEF at presentation, likely explaining the improved outcomes in these women. These findings underscore the need for early monitoring and diagnosis, especially in at-risk and underserved populations.

Entities:  

Keywords:  cardiomyopathies; healthcare disparities; preeclampsia; pregnancy; women

Mesh:

Year:  2019        PMID: 31707840      PMCID: PMC6906246          DOI: 10.1161/HYPERTENSIONAHA.119.13291

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  20 in total

1.  Poor outcome of indigent patients with peripartum cardiomyopathy in the United States.

Authors:  Kalgi A Modi; Sandra Illum; Karim Jariatul; Gloria Caldito; Pratap C Reddy
Journal:  Am J Obstet Gynecol       Date:  2009-06-28       Impact factor: 8.661

Review 2.  The current state of ethnic and racial disparities in cardiovascular care: lessons from the past and opportunities for the future.

Authors:  Jennifer Lewey; Niteesh K Choudhry
Journal:  Curr Cardiol Rep       Date:  2014       Impact factor: 2.931

3.  First-trimester prediction of preeclampsia in nulliparous women at low risk.

Authors:  Leslie Myatt; Rebecca G Clifton; James M Roberts; Catherine Y Spong; John C Hauth; Michael W Varner; John M Thorp; Brian M Mercer; Alan M Peaceman; Susan M Ramin; Marshall W Carpenter; Jay D Iams; Anthony Sciscione; Margaret Harper; Jorge E Tolosa; George Saade; Yoram Sorokin; Garland D Anderson
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

4.  Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach.

Authors:  Daniel G Kramer; Thomas A Trikalinos; David M Kent; George V Antonopoulos; Marvin A Konstam; James E Udelson
Journal:  J Am Coll Cardiol       Date:  2010-07-27       Impact factor: 24.094

5.  Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy.

Authors:  Sorel Goland; Fahed Bitar; Kalgi Modi; Jordan Safirstein; Angela Ro; James Mirocha; Nudrat Khatri; Uri Elkayam
Journal:  J Card Fail       Date:  2011-03-11       Impact factor: 5.712

6.  Recovery from severe heart failure following peripartum cardiomyopathy.

Authors:  James D Fett; Herriot Sannon; Emmeline Thélisma; Therese Sprunger; Venkita Suresh
Journal:  Int J Gynaecol Obstet       Date:  2008-11-26       Impact factor: 3.561

7.  Predictors of outcome in 176 South African patients with peripartum cardiomyopathy.

Authors:  Lori A Blauwet; Elena Libhaber; Olaf Forster; Kemi Tibazarwa; Alex Mebazaa; Denise Hilfiker-Kleiner; Karen Sliwa
Journal:  Heart       Date:  2012-10-31       Impact factor: 5.994

8.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Authors:  M Packer; M R Bristow; J N Cohn; W S Colucci; M B Fowler; E M Gilbert; N H Shusterman
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

9.  Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.

Authors:  Ian S Patten; Sarosh Rana; Sajid Shahul; Glenn C Rowe; Cholsoon Jang; Laura Liu; Michele R Hacker; Julie S Rhee; John Mitchell; Feroze Mahmood; Philip Hess; Caitlin Farrell; Nicole Koulisis; Eliyahu V Khankin; Suzanne D Burke; Igor Tudorache; Johann Bauersachs; Federica del Monte; Denise Hilfiker-Kleiner; S Ananth Karumanchi; Zoltan Arany
Journal:  Nature       Date:  2012-05-09       Impact factor: 49.962

10.  Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.

Authors:  A Haghikia; E Podewski; E Libhaber; S Labidi; D Fischer; P Roentgen; D Tsikas; J Jordan; R Lichtinghagen; C S von Kaisenberg; I Struman; N Bovy; K Sliwa; J Bauersachs; Denise Hilfiker-Kleiner
Journal:  Basic Res Cardiol       Date:  2013-06-28       Impact factor: 17.165

View more
  5 in total

Review 1.  A bibliometric review of peripartum cardiomyopathy compared to other cardiomyopathies using artificial intelligence and machine learning.

Authors:  M Grosser; H Lin; M Wu; Y Zhang; S Tipper; D Venter; J Lu; C G Dos Remedios
Journal:  Biophys Rev       Date:  2022-02-09

Review 2.  Pathophysiology and risk factors of peripartum cardiomyopathy.

Authors:  Martijn F Hoes; Zoltan Arany; Johann Bauersachs; Denise Hilfiker-Kleiner; Mark C Petrie; Karen Sliwa; Peter van der Meer
Journal:  Nat Rev Cardiol       Date:  2022-01-11       Impact factor: 49.421

3.  Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy.

Authors:  Rahul Goli; Jian Li; Jeff Brandimarto; Lisa D Levine; Valerie Riis; Quentin McAfee; Steven DePalma; Alireza Haghighi; J G Seidman; Christine E Seidman; Daniel Jacoby; George Macones; Daniel P Judge; Sarosh Rana; Kenneth B Margulies; Thomas P Cappola; Rami Alharethi; Julie Damp; Eileen Hsich; Uri Elkayam; Richard Sheppard; Jeffrey D Alexis; John Boehmer; Chizuko Kamiya; Finn Gustafsson; Peter Damm; Anne S Ersbøll; Sorel Goland; Denise Hilfiker-Kleiner; Dennis M McNamara; Zolt Arany
Journal:  Circulation       Date:  2021-04-20       Impact factor: 29.690

4.  Heart rate as an early predictor of severe cardiomyopathy and increased mortality in peripartum cardiomyopathy.

Authors:  Ryan Cooney; John R Scott; Madeline Mahowald; Elizabeth Langen; Garima Sharma; David P Kao; Melinda B Davis
Journal:  Clin Cardiol       Date:  2022-02-07       Impact factor: 2.882

5.  Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry.

Authors:  Alice M Jackson; Mark C Petrie; Alexandra Frogoudaki; Cécile Laroche; Finn Gustafsson; Bassem Ibrahim; Alexandre Mebazaa; Mark R Johnson; Petar M Seferovic; Vera Regitz-Zagrosek; Amam Mbakwem; Michael Böhm; Hawani S Prameswari; Doaa A Fouad; Sorel Goland; Albertino Damasceno; Kamilu Karaye; Hasan A Farhan; Righab Hamdan; Aldo P Maggioni; Karen Sliwa; Johann Bauersachs; Peter van der Meer
Journal:  Eur J Heart Fail       Date:  2021-08-25       Impact factor: 17.349

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.